64
Views
23
CrossRef citations to date
0
Altmetric
Review

Novel targeted drug therapies for the treatment of childhood acute leukemia

, , , &
Pages 145-158 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ertugrul Eryılmaz & Cengiz Canpolat. (2017) Novel agents for the treatment of childhood leukemia: an update. OncoTargets and Therapy 10, pages 3299-3306.
Read now
Xiaoliang Liu, Fei Ye, Josephine Wu, Brian How, Wei Li & David Y. Zhang. (2015) Signaling Proteins and Pathways Affected by Flavonoids in Leukemia Cells. Nutrition and Cancer 67:2, pages 238-249.
Read now
Craig A. Portell & Anjali S. Advani. (2014) Novel targeted therapies in acute lymphoblastic leukemia. Leukemia & Lymphoma 55:4, pages 737-748.
Read now

Articles from other publishers (20)

Harsh Goel, Rahul Kumar, Pranay Tanwar, Tarun Kumar Upadhyay, Fahad Khan, Pratibha Pandey, Sojin Kang, Myunghan Moon, Jinwon Choi, Min Choi, Moon Nyeo Park, Bonglee Kim & Mohd Saeed. (2023) Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia. Biomedicine & Pharmacotherapy 160, pages 114351.
Crossref
Georgina Claire Morris, Gillian Dean, Suneeta Soni, Sangeetha Sundaram, Nicola Fearnley & Janet Diane Wilson. (2022) Outcomes and experiences of using oral voriconazole with or without concomitant topical agents to treat refractory vulvovaginal yeast infections. International Journal of STD & AIDS 33:13, pages 1134-1141.
Crossref
Fatemeh Alikarami, Majid Safa, Mohammad Faranoush, Parisa Hayat & Ahmad Kazemi. (2017) Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin. Biomedicine & Pharmacotherapy 94, pages 1077-1093.
Crossref
Francisco Bautista, Soledad Gallego, Adela Cañete, Jaume Mora, Cristina Díaz de Heredia, Ofelia Cruz, José María Fernández, Susana Rives, Pablo Berlanga, Raquel Hladun, Antonio Juan Ribelles, Luis Madero, Manuel Ramírez, Rafael Fernández Delgado, Antonio Pérez-Martínez, Cristina Mata, Anna Llort, Javier Martín Broto, María Elena Cela, Gema Ramírez, Constantino Sábado, Tomás Acha, Itziar Astigarraga, Ana Sastre, Ascensión Muñoz, Mercedes Guibelalde & Lucas Moreno. (2017) Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacional. Anales de Pediatría 87:3, pages 155-163.
Crossref
Francisco Bautista, Soledad Gallego, Adela Cañete, Jaume Mora, Cristina Díaz de Heredia, Ofelia Cruz, José María Fernández, Susana Rives, Pablo Berlanga, Raquel Hladun, Antonio Juan Ribelles, Luis Madero, Manuel Ramírez, Rafael Fernández Delgado, Antonio Pérez-Martínez, Cristina Mata, Anna Llort, Javier Martín Broto, María Elena Cela, Gema Ramírez, Constantino Sábado, Tomás Acha, Itziar Astigarraga, Ana Sastre, Ascensión Muñoz, Mercedes Guibelalde & Lucas Moreno. (2017) Early clinical trials in paediatric oncology in Spain: A nationwide perspective. Anales de Pediatría (English Edition) 87:3, pages 155-163.
Crossref
Bao Nguyen, Allen B. Williams, David J. Young, Hayley Ma, Li Li, Mark Levis, Patrick Brown & Donald Small. (2017) FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors. Oncotarget 8:7, pages 10931-10944.
Crossref
F. Bautista, S. Gallego, A. Cañete, J. Mora, C. Diaz de Heredia, O. Cruz, J. M. Fernández, S. Rives, L. Madero, V. Castel, M. E. Cela, G. Ramírez, C. Sábado, T. Acha, I. Astigarraga, A. Sastre, A. Muñoz, M. Guibelalde & L. Moreno. (2015) Landscape of early clinical trials for childhood and adolescence cancer in Spain. Clinical and Translational Oncology 18:7, pages 708-713.
Crossref
Tomasz Cierpicki & Jolanta Grembecka. (2015) Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?. Immunological Reviews 263:1, pages 279-301.
Crossref
Thomas Linke, Matthew T. Aspelund, Christopher Thompson, Guoling Xi, Andrew Fulton, Michaela Wendeler, Timothy M. Pabst, Xiangyang Wang, William K. Wang, Kripa Ram & Alan K. Hunter. (2014) Development and scale‐up of a commercial fed batch refolding process for an anti‐ CD 22 two chain immunotoxin . Biotechnology Progress 30:6, pages 1380-1389.
Crossref
Dario Campana & Ching-Hon Pui. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1849 1872.e11 .
Karolina Nemes, Anna Sebestyén, Ágnes Márk, Melinda Hajdu, István Kenessey, Tamás Sticz, Eszter Nagy, Gábor Barna, Zsófia Váradi, Gábor Kovács, László Kopper & Monika Csóka. (2013) Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL). PLoS ONE 8:4, pages e59335.
Crossref
Thomas Linke, Jinhua Feng, Kathy Yu, Hyun Jun Kim, Ziping Wei, Yang Wang, William K. Wang & Alan K. Hunter. (2012) Process scale separation of an anti-CD22 immunotoxin charge variant. Journal of Chromatography A 1260, pages 120-125.
Crossref
Jeffrey E. Rubnitz, Hiroto Inaba & Raul C. Ribeiro. 2013. Childhood Leukemias. Childhood Leukemias 395 420 .
William L. Carroll & Elizabeth A. Raetz. (2012) Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia. The Journal of Pediatrics 160:1, pages 10-18.
Crossref
Lilian KusterReinhard GrausenburgerGerhard FukaUlrike KaindlGerd KrapfAndrea InthalGeorg MannMaximilian KauerJohannes RainerReinhard KoflerAndrew HallMarkus MetzlerLüder Hinrich MeyerClaus Meyer, Jochen Harbott, Rolf Marschalek, Sabine StrehlOskar A. HaasRenate Panzer-Grümayer. (2011) ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood 117:9, pages 2658-2667.
Crossref
Riccardo Masetti, Salvatore Serravalle, Carlotta Biagi & Andrea Pession. (2011) The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias. Journal of Biomedicine and Biotechnology 2011, pages 1-9.
Crossref
Chas Bountra, Udo Oppermann & Tom D. Heightman. 2011. Molecular and Functional Models in Neuropsychiatry. Molecular and Functional Models in Neuropsychiatry 281 322 .
Diptiman Chanda, Sanjay Kumar & Selvarangan Ponnazhagan. (2010) Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. Journal of Cellular Biochemistry 111:2, pages 249-257.
Crossref
Shun’ichiro Taniguchi, Minoru Fujimori, Takayuki Sasaki, Hiroko Tsutsui, Yuko Shimatani, Keiichi Seki & Jun Amano. (2010) Targeting solid tumors with non-pathogenic obligate anaerobic bacteria. Cancer Science 101:9, pages 1925-1932.
Crossref
Yuqiu Jiang & Mu Wang. (2010) Personalized medicine in oncology: tailoring the right drug to the right patient. Biomarkers in Medicine 4:4, pages 523-533.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.